BREAKING NEWS
Donald Trumph wins US presidential elections
Buy Aurobindo Pharma with a target of 181: Deepak Mohoni
Aurobindo Pharma is a buy with a stop loss of 171.5 and a target of 181.
By

| Updated:
In a chat with Deepak Mohoni, Director, trendwatchindia.com, shares his views on Aurobindo Pharma Ltd. ET Now: What is your call on Aurobindo Pharma? Deepak Mohoni: Aurobindo Pharma is a buy with a stop loss of 171.5 and a target of 181.
LOGIN & CLAIM
50 TIMESPOINTS
Loading next story

Business News › Markets › Stocks › Recos › Buy Aurobindo Pharma with a target of 181: Deepak MohoniSuccess
This article has been saved
